Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Laurus Labs Ltd.
Swot
Laurus Labs Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Laurus Labs Ltd. has 18 Strengths, 13 Weaknesses, 2 Opportunities and 3 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(18)
Weakness
(13)
Opportunity
(2)
Threats
(3)
Others
(4)
Price crossing above SMA20 today, and greater than SMA5
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Expensive Stars (DVM)
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over 1 Year
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Results Screener: Stocks with upcoming results which are seeing positive shifts in share price
Relative Outperformance versus Industry over 1 Month
Growth in Net Profit with increasing Profit Margin (QoQ)
Increasing Revenue every quarter for the past 2 quarters
Increasing profits every quarter for the past 2 quarters
Book Value per share Improving for last 2 years
Top Gainers
Volume Shockers
Stocks near 52 Week High with Significant Volumes
Stocks Outperforming their Industry Price Change in the Quarter
Promoters increased pledged shares QoQ
PE higher than Industry PE
PEG greater than Industry PEG
High PE (PE > 40)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Inefficient use of capital to generate profits - RoCE declining in the last 2 years
Inefficient use of shareholder funds - ROE declining in the last 2 years
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Annual net profit declining for last 2 years
Increasing Trend in Non-Core Income
High promoter stock pledges
Highest increase in pledges by promoters
Sell Zone: Stocks in the sell zone based on days traded at current PE and P/BV
Brokers upgraded recommendation or target price in the past three months
Highest FII stock holdings
MFs decreased their shareholding last quarter
US FDA Warning Letter
Red Flag: Companies seeing significant coronavirus impact
Promoters increasing shareholding QoQ
Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
Decline in Quarterly Net Profit with falling Profit Margin (YoY)
